Dr. Mohammed Al-Ourani, MD

Dr. Al-Ourani practices at Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network.

Dr. Al-Ourani's NPI, 1245462290, was assigned on August 10, 2009. Dr. Al-Ourani holds West Virginia license 25551.

Dr. Al-Ourani's primary practice is Cabell Huntington Hospital, at 1340 Hal Greer Boulevard, Huntington, WV 25701 in Cabell County. The practice phone is (304) 526-2000.

Dr. Al-Ourani's primary practice is Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network. Dr. Al-Ourani is also affiliated with St. Mary's Medical Center. The medical group on file is Marshall Health. Dmand AI also links Dr. Al-Ourani to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Ourani practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Al-Ourani's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Al-Ourani's licenses on file in 2 states: West Virginia and Kentucky.

CMS data shows 779 Medicare services from Dr. Al-Ourani across 11 procedure codes in 2024, for 419 Medicare patients. Medicare paid $75,807 for them.

CMS counts 419 Medicare patients who saw Dr. Al-Ourani in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Ourani's median patient age at 68, with 56% women.

In 2024, Dr. Al-Ourani wrote 2,065 Medicare Part D claims for 272 patients. 33% of them were for generic drugs. CMS names the drug for 2,012 of them, across 31 drugs with 11 or more claims each, at $846,256 in total drug cost. In 2023, CMS named 1,704 claims across 24 drugs.

Dr. Al-Ourani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 36 general payments to Dr. Al-Ourani from 17 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 77% of the total. Covidien LP paid the most, $339.